Lumen Bioscience has published data demonstrating a needle-free, spirulina-produced recombinant vaccine that protects against malaria. …
Hope that malaria could be eradicated forever has been given a boost after new findings…
TikoMed has announced the inclusion in bioRxiv of an in vitro study examining the ability…
U.S. biomanufacturer Manus Bio has received a fourth award from the Bill & Melinda Gates…
A Belgian university spinoff has generated the biggest seed capital financing in the institution’s history.…
Genetic engineering is breaking new ground in the control of mosquito-borne diseases. However, a genetic…
A vaccine to treat dengue fever, the mosquito-borne disease, is the end goal of two…
Construction of the first African messenger RNA (mRNA) manufacturing facility has started in Africa. This…
The UK biotech Emergex Vaccines has raised over €9.9M in a Series A funding round,…
Update (18/11/2019): French biotech Valneva has revealed additional phase I results concerning its experimental chikungunya…
Vienna-based Themis Biosciences has raised €40M in a Series D round to fund a phase…
The market is in sight for the first potential vaccine for the chikungunya virus, as…
